Johnson & Johnson (NYSE:JNJ) has won a $227.6 million maximum fixed-price contract for spinal procedure implant packages with the US Department of Defense’s Logistics Agency, according to a newly released DoD posting.
The contract comes with a one-year base and an additional four single year option periods, and will position J&J to supply spinal implant devices to the Air Force, Army, Navy, Marines, Coast Guard and federal civilian agencies’ according to the release.
The maximum $227.6 million amount is for the entire life of the contract, which has a final performance completion date of July 26, 2023, according to the DoD.
Earlier this month, Johnson & Johnson posted second-quarter sales and earnings that topped the consensus forecast, prompting the healthcare giant to tighten its outlook on the rest of the year.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.